LingLi is a smart electronic stethoscope, which can carry out auscultation, monotone ECG measurement, data acquisition, recording and wireless transmission. By using the supporting App, the heart sounds and ECG data will be uploaded to the cloud and analyzed. Considering the stability, facility and wide applicability, the product is perfect suitable for clinical and home use.

Before the world even imagined that 4 million drug-eluting stents would be available in 36 countries around the world, the founders of MicroPort® were imagining how they would impact the lives of people through technology. Their belief was that these medical technologies must be accessible to everyone. Relentless innovation has inspired promising product development and initiated strategic investments in emerging scientific platforms. Today, we see a promising path forward, one that addresses the most challenging healthcare issues, while allowing us to explore the ways to accelerate and broaden access to medical technology innovation.

MicroPort® is a global medical devices company, founded on the belief that every person has the right to high quality medical treatments and to live longer and healthier lives. All our solutions are designed to deliver on that belief. Our close collaboration with doctors and medical societies helps us accelerate innovation and develop solutions to transform medical treatment. Today, MicroPort® operates in multiple international markets across multiple fields, including orthopedics, cardiovascular intervention, cardiac rhythm management, electro-physiology, endovascular, peripheral vascular intervention, among others.